Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients (Q33586790)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

lessons learned

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Locarnini S

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Birch C

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

536-550

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

HIV therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Review: Present and future directions in the treatment of chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing the natural history of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The accuracy of reverse transcriptase from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in chronic hepatitis B. An analysis of 379 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of T‐helper cell subsets and crossregulation in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of interferon on hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus surface antigen and polymerase gene variants: Potential virological and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of hepatitis B virus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

RNA virus populations as quasispecies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics of HIV: implications for drug development and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with famciclovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Single-Dose Study to Assess the Penetration of Stavudine Into Human Cerebrospinal Fluid in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption and Elimination Kinetics of Zidovudine in the Cerebrospinal Fluid in HIV-1-Infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The entry of antiviral and antiretroviral drugs into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of extrahepatic replication of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B: the therapeutic challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy for human immunodeficiency virus infection -- what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral counts count in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitochondrial toxicity of antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to hit HIV, early and hard.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(99)80118-4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

release_hvh6uyznrfdp5kwzo5pw54qr7i

1 reference

https://api.fatcat.wiki/v0/release/hvh6uyznrfdp5kwzo5pw54qr7i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33586790&oldid=1965088521"